I90Mike | 3 points
NCT04405843 RCT does not show ivermectin reducing duration of mild COVID symptomsAn article in El Pais (Colombia) summarizes results of the EPIC randomized controlled trial in Cali, Colombia. In a study of about 400 patients, the duration of symptoms was about the same in both the placebo group and the group treated with ivermectin, 300 micrograms / kg, once daily for 5 days. About 3% of the placebo group and 2% of the ivermectin group needed hospitalization. Since this difference is only 2 people out of 400, it's not statistically significant and could very well be random.
Of course, as the lead researcher points out, there are other trials ongoing with different dosing and different endpoints. Notably this study did not address prophylaxis, and did not address moderate to severe COVID.
[-] Murky-Lengthiness | 5 points
3% hospitalizations in a country that has a 3.4 percentage mortality?
[-] Impressive_Run8581 | 3 points
Crap endpoints. IVM use didn't make me better looking or my junk longer.
[-] movethroughit | 1 points
Is this the one that placed treated patients in the control group?
I think the use of IVM MUST be used with other drugs as in the I-MASK+ protocol. The handed out packets with IVM contain other essential drugs.
Yes you are correct. ivm is not a blood thinner, hence the hypercoagulative state that a majority of covid victims are in that category.
Aspirin or both aspirin and lysine help in that department.
As well, dietary restrictions as eliminating coffee, eating foods low in arginine ratio to lysine, as well as food low in fiber.
Look up Gustav Aguirre, read a few of his papers.
[-] TrumpLyftAlles | 1 points
News of this study was posted to the sub a couple days ago, here.
Please continue the conversation there.
[-] Murky-Lengthiness | 6 points | Jan 05 2021 18:40:41
The hospitalization rate is very suspicious
permalink